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authors evaluating the computer analysis knew how to
better treat the pain of these patients than the nephrol-
ogist at the bedside suggests an unmerited confidence.
Without consultation with the patients at the bedside, a
blind guideline suggested by the authors could be po-
tentially lethal. We always wish to encourage young in-
vestigators, and suggest that they should re-evaluate their
study and develop a design that includes some evaluation
of the pain and its treatment at the bedside. As William
Osler noted, “The hospital is the only proper place to rear
a true disciple of Aesculepius.”[3]
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Reply from the Authors
Dr. Diskin raises several interesting points. However,
as an observational study, the DOPPS cannot provide
the type of analysis suggested—evaluating the type of
pain experienced and the corresponding use of different
agents. The observational nature of the DOPPS dataset
has been well described, and its numerous publications
have examined associations and correlations of outcomes
with a constellation of variables. Our study addressed
many outcomes and variables associated with analgesic
use. The introduction clearly states that there are poten-
tial problems associated with the use of analgesics in in-
dividuals with diminished or no kidney function and pro-
vides a thorough list of potential problems.
Dr. Diskin correctly points out that we made no dis-
tinction in the various types of pain, and thus, cannot dis-
tinguish patients who were crippled from severe coronary
artery disease or diabetic patients with neuropathic pain.
We have reanalyzed our data to examine self-reported
pain and the use of analgesics at baseline, omitting those
patients with angina and peripheral neuropathy. Interest-
ingly, there were no substantial differences in the findings.
The proportion of patients reporting moderate to very se-
vere pain within the last four weeks having received no
analgesics changed from 73.8% (original) to 74.3% (with
angina and peripheral neuropathy excluded). Similarly,
the proportion of those responding that pain interfered
with their normal work to a moderate to extreme ex-
tent with no analgesic prescription changed from 74.7%
(original) to 74.4% (with exclusions). Thus, Dr. Diskin’s
hypothesis does not appear to be supported by these new
analyses.
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